Glucagon-like Peptide 2 (Human)
- Code:
- 4376-v
- Name:
- Glucagon-like Peptide 2 (Human)
- GLP-2 (Human)
- His-Ala-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Ala-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp
- (M.W. 3766.1) C165H254N44O55S
- Food Intake Suppressor
- main
- more information
- reference
main
- Purity:
- ≧98.0% (HPLC)
- Storage:
- -20 ℃
- Production:
- Synthetic Product
Solubility: 25 mM Phosphate buffer (pH 7.4) or 0.1% NH4OH (0.1 mM)
more information
- Category:
- Biologically Active Peptides
reference
- B. Hartmann, A.H. Johnsen, C. Ørskov, K. Adelhorst, L. Thim, and J.J. Holst, Peptides, 21, 73 (2000). (Pharmacol.)
- M. Tang-Christensen, P.J. Larsen, J. Thulesen, J. Rømer, and N. Vrang, Nat. Med., 6, 802 (2000). (Pharmacol.)
- D.J. Drucker, Gut, 50, 428 (2002). (Review)
- K. Wallis, J.R.F. Walters, and A. Forbes, Aliment. Pharmacol. Ther., 25, 365 (2007). (Review)
- P.E. Dubé and P.L. Brubaker, Am. J. Physiol. Endocrinol. Metab., 293, E460 (2007). (Review)
- K.J. Rowland and P.L. Brubaker, Mol. Cell. Endocrinol., 288, 63 (2008). (Review)
- R. Yazbeck, G.S. Howarth, and C.A. Abbott, Cytokine Growth Factor Rev., 20, 175 (2009). (Review)
- R. Yazbeck, C.A. Abbott, and G.S. Howarth, Curr. Opin. Investig. Drugs, 11, 440 (2010). (Review)
- E. Blázquez, E. Alvarez, M. Navarro, I. Roncero, F. Rodriíguez-Fonseca, J.A. Chowen, and J.A. Zueco, Mol. Neurobiol., 18, 157 (1998). (Review)
- G. van Dijk and T.E. Thiele, Neuropeptides, 33, 406 (1999). (Review)
SDS:他の製品を検索する
